Epigenetic changes: The missing link

Best Practice and Research: Clinical Rheumatology

Volumn 28, Issue 4, 2014, Pages 577-587

  Kyburz, Diego ^a,b,c   Karouzakis, Emmanuel ^c   Ospelt, Caroline ^c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Acetylation; Environment; Epigenetic; HDAC; Histone; Methylation; microRNA; miR; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DNA METHYLTRANSFERASE 1; GIVINOSTAT; HISTONE DEACETYLASE; LONG UNTRANSLATED RNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICRORNA; MICRORNA 146A; MICRORNA 155; UNTRANSLATED RNA;

ACETYLATION; AUTOIMMUNE DISEASE; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HISTONE MODIFICATION; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SMOKING; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; RISK FACTOR;

ARTHRITIS, RHEUMATOID; EPIGENESIS, GENETIC; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS;

EID: 84927713835     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2014.10.014     Document Type: Review

References (84)

1. Bax M, van Heemst J, Huizinga TW, et al. Genetics of rheumatoid arthritis: what have we learned? Immunogenetics 2011; 63(8):459-66.
2. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54(1): 38-46.
3. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010;28(10):1057-68.
4. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012;13(7):484-92.
5. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res 2011;21(3):381-95.
6. Bostick M, Kim JK, Esteve PO, et al. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007;317(5845):1760-4.
7. Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet 2013;14(3):204-20.
8. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev 2011;25(10):1010-22.
9. Norris DP, Patel D, Kay GF, et al. Evidence that random and imprinted Xist expression is controlled by preemptive methylation. Cell 1994;77(1):41-51.
10. Wu H, Zhang Y. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell 2014;156(1-2):45-68.
11. Dawson MA, Kouzarides T, Huntly BJ. Targeting epigenetic readers in cancer. N Engl J Med 2012;367(7):647-57.
12. Chapman-Rothe N, Brown R. Prospects for epigenetic compounds in the treatment of autoimmune disease. Adv Exp Med Biol 2011;711:150-61.
13. Deardorff MA, Bando M, Nakato R, et al. HDAC8 mutations in cornelia de lange syndrome affect the cohesin acetylation cycle. Nature 2012;489(7415):313-7.
14. Giblin W, Skinner ME, Lombard DB. Sirtuins: guardians of mammalian healthspan. trends in genetics. TIG 2014;30(7): 271-86.
15. West AC, Johnstone RW. New and emerging HDAC inhibitors for cancer treatment. J Clin Invest 2014;124(1):30-9.
16. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4(12):988-93.
17. Brannan CI, Dees EC, Ingram RS, et al. The product of the H19 gene may function as an RNA. Mol Cell Biol 1990;10(1): 28-36.
18. Brockdorff N, Ashworth A, Kay GF, et al. The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell 1992;71(3):515-26.
19. Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in caenorhabditis elegans. Nature 2000;403(6772):901-6.
20. Stuhlmuller B, Kunisch E, Franz J, et al. Detection of oncofetal h19 RNA in rheumatoid arthritis synovial tissue. Am J Pathol 2003;163(3):901-11.
21. Hao Y, Crenshaw T, Moulton T, et al. Tumour-suppressor activity of H19 RNA. Nature 1993;365(6448):764-7.
22. Rachmilewitz J, Elkin M, Rosensaft J, et al. H19 expression and tumorigenicity of choriocarcinoma derived cell lines. Oncogene 1995;11(5):863-70.
23. Luo M, Li Z, Wang W, et al. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett 2013;333(2):213-21.
24. Pink RC, Wicks K, Caley DP, et al. Pseudogenes: pseudo-functional or key regulators in health and disease? RNA 2011; 17(5):792-8.
25. Jopling CL, Yi M, Lancaster AM, et al. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 2005;309(5740):1577-81.
26. Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013;368(18): 1685-94.
27. Neidhart M, Rethage J, Kuchen S, et al. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum 2000;43(12): 2634-47.
28. Karouzakis E, Gay RE, Michel BA, et al. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2009;60(12):3613-22.
29. Karouzakis E, Rengel Y, Jungel A, et al. DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun 2011;12(8):643-52.
30. Park SH, Kim SK, Choe JY, et al. Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis. Mol Cells 2013;35(4):298-304.
31. Takami N, Osawa K, Miura Y, et al. Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheum 2006;54(3):779-87.
32. Nakano K, Whitaker JW, Boyle DL, et al. DNA methylome signature in rheumatoid arthritis. Ann Rheum Dis 2013;72(1): 110-7.
33. de la Rica L, Urquiza JM, Gomez-Cabrero D, et al. Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expression. J Autoimmun 2013;41:6-16.
34. Liu Y, Aryee MJ, Padyukov L, et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol 2013;31(2):142-7.
35. Liao J, Liang G, Xie S, et al. CD40L demethylation in CD4(+) T cells from women with rheumatoid arthritis. Clin Immunol 2012;145(1):13-8.
36. Nile CJ, Read RC, Akil M, et al. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum 2008;58(9):2686-93.
37. Glant TT, Besenyei T, Kadar A, et al. Differentially expressed epigenome modifiers, including aurora kinases A and B, in immune cells in rheumatoid arthritis in humans and mouse models. Arthritis Rheum 2013;65(7):1725-35.
38. Wolter S, Doerrie A, Weber A, et al. c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene. Mol Cell Biol 2008;28(13):4407-23.
39. Huber LC, Brock M, Hemmatazad H, et al. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum 2007;56(4):1087-93.
40. Kawabata T, Nishida K, Takasugi K, et al. Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis. Arthritis Res Ther 2010;12(4):R133.
41. Maciejewska-Rodrigues H, Karouzakis E, Strietholt S, et al. Epigenetics and rheumatoid arthritis: the role of SENP1 in the regulation of MMP-1 expression. J Autoimmun 2010;35(1):15-22.
42. Grabiec AM, Krausz S, de Jager W, et al. Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J Immunol 2010;184(5):2718-28.
43. Bordone L, Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 2005; 6(4):298-305.
44. Schug TT, Xu Q, Gao H, et al. Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol Cell Biol 2010;30(19):4712-21.
45. Niederer F, Ospelt C, Brentano F, et al. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Ann Rheum Dis 2011;70(10):1866-73.
46. Lee HS, Ka SO, Lee SM, et al. Overexpression of sirtuin 6 suppresses inflammatory responses and bone destruction in mice with collagen-induced arthritis. Arthritis Rheum 2013;65(7):1776-85.
47. Nakasa T, Miyaki S, Okubo A, et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008;58(5):1284-92.
48. Pauley KM, Satoh M, Chan AL, et al. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008;10(4):R101.
49. Stanczyk J, Pedrioli DM, Brentano F, et al. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 2008;58(4):1001-9.
50. O'Connell RM, Taganov KD, Boldin MP, et al. microRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007;104(5):1604-9.
51. Kurowska-Stolarska M, Alivernini S, Ballantine LE, et al. microRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A 2011;108(27):11193-8.
52. O'Connell RM, Chaudhuri AA, Rao DS, et al. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A 2009;106(17):7113-8.
53. Bluml S, Bonelli M, Niederreiter B, et al. Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum 2011;63(5):1281-8.
54. Davis TE, Kis-Toth K, Tsokos GC. A114: methylprednisolone-induced inhibition of miR-155 expression increases SOCS1- Driven suppression of cytokine signaling. Arthritis Rheumatol 2014;66(Suppl. 11):S151.
55. Lu LF, Boldin MP, Chaudhry A, et al. Function of miR-146a in controlling treg cell-mediated regulation of Th1 responses. Cell 2010;142(6):914-29.
56. Murata K, Yoshitomi H, Tanida S, et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2010;12(3):R86.
57. Li J, Wan Y, Guo Q, et al. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther 2010;12(3):R81.
58. Nakasa T, Shibuya H, Nagata Y, et al. The inhibitory effect of microRNA-146a expression on bone destruction in collageninduced arthritis. Arthritis Rheum 2011;63(6):1582-90.
59. Chatzikyriakidou A, Voulgari PV, Georgiou I, et al. A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Jt Bone Spine 2010; 77(5):411-3.
60. Klareskog L, Gregersen PK, Huizinga TW. Prevention of autoimmune rheumatic disease: state of the art and future perspectives. Ann Rheum Dis 2010;69(12):2062-6.
61. Makrygiannakis D, Hermansson M, Ulfgren AK, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008;67(10):1488-92.
62. Kazantseva MG, Highton J, Stamp LK, et al. Dendritic cells provide a potential link between smoking and inflammation in rheumatoid arthritis. Arthritis Res Ther 2012;14(5):R208.
63. Ospelt C, Camici GG, Engler A, et al. Smoking induces transcription of the heat shock protein system in the joints. Ann Rheum Dis 2014;73(7):1423-6.
64. Belinsky SA, PalmisanoWA, Gilliland FD, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002;62(8):2370-7.
65. Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N. Engl J Med 2005;352(19):1967-76.
66. Sundar IK, Nevid MZ, Friedman AE, et al. Cigarette smoke induces distinct histone modifications in lung cells: implications for the pathogenesis of COPD and lung cancer. J Proteome Res 2014;13(2):982-96.
67. Engler A, Niederer F, Klein K, et al. SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts. J Mol Med 2014;92(7):757-67.
68. Carlens C, Hergens MP, Grunewald J, et al. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit care Med 2010;181(11):1217-22.
69. Stolt P, Yahya A, Bengtsson C, et al. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann Rheum Dis 2010;69(6):1072-6.
70. Hart JE, Kallberg H, Laden F, et al. Ambient air pollution exposures and risk of rheumatoid arthritis. Arthritis Care Res Hob 2013;65(7):1190-6.
71. Hart JE, Kallberg H, Laden F, et al. Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case-control study. Ann Rheum Dis 2013;72(6):888-94.
72. Salliot C, Bombardier C, Saraux A, et al. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 ∗01 and/or ∗04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort. Ann Rheum Dis 2010;69(9):1683-6.
73. Dai R, Phillips RA, Zhang Y, et al. Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 2008;112(12):4591-7.
74. Di Costanzo A, Del Gaudio N, Migliaccio A, et al. Epigenetic drugs against cancer: an evolving landscape. Archives Toxicol 2014;88(9):1651-68.
75. Vojinovic J, Damjanov N. HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis. Mol Med 2011; 17(5-6):397-403.
76. Nakamachi Y, Kawano S, Takenokuchi M, et al. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 2009;60(5):1294-304.
77. Niimoto T, Nakasa T, Ishikawa M, et al. MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet Disord 2010;11:209.
78. Zhu S, Pan W, Song X, et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat Med 2012;18(7):1077-86.
79. Stanczyk J, Ospelt C, Karouzakis E, et al. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum 2011;63(2):373-81.
80. Niederer F, Trenkmann M, Ospelt C, et al. Downregulation of microRNA-34a∗ in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance. Arthritis Rheum 2011;64(6):1771-9.
81. Fulci V, Scappucci G, Sebastiani GD, et al. miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol 2010;71(2):206-11.
82. Shibuya H, Nakasa T, Adachi N, et al. Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation. Mod Rheumatol 2013;23(4):674-85.
83. Murata K, Furu M, Yoshitomi H, et al. Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis. PLoS One 2013;8(7). e69118.
84. Pandis I, Ospelt C, Karagianni N, et al. Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model. Ann Rheum Dis 2012;71(10):1716-23.